Summary by Moomoo AI
Jun Shing Tai Pharmaceutical-B (Stock Code: 2511) announces that a Board Meeting will be held on Wednesday, March 27, 2024. The primary purpose of which is to review and approve the audited annual results of the Company and its subsidiaries for the year ended December 31, 2023 and their publication. The meeting will be chaired by Dr. Liu Liping, Executive Director and Chief Executive Officer, and will be attended by other Board members, including Ms. Yu Meng, Executive Director, Dr. Zhu Xun, Mr. Ma Li-Hung and Mr. Jiang Feng, as well as Independent Non-Executive Directors Mr. Tan Yin, Dr. Li Jing and Mr. Kung De Wei. In addition to reviewing the annual results, the meeting will deal with other matters.